10-Q Filing

XILIO THERAPEUTICS, INC. CIK: 1840233 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001558370-23-014711`
Period End Date	20230630
Filing Date	20230814
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	xlo-20230630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 50 Cash Flow Statement 54 Stockholders Equity 25

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.39M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$159.41M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$75.38M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.04M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.11M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$124.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$78.42M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.56M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.57M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.25M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.54M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.80M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.37M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.58M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.52M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.43M	shares	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$267.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$197.00K	USD	Point-in-time
Total assets	`Assets`	$92.36M	USD	Point-in-time
Total assets	`Assets`	$139.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.12M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$945.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.33M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.14M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$981.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$918.00K	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$7.14M	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$6.67M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.29M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$3.17M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$9.19M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.68M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$45.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$7.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$33.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$24.98M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at June 30, 2023 and December 31, 2022; 27,539,620 shares issued and 27,518,895 shares outstanding at June 30, 2023; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at June 30, 2023 and December 31, 2022; 27,539,620 shares issued and 27,518,895 shares outstanding at June 30, 2023; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$354.75M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$358.48M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-249.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-291.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$105.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$67.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$84.79M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$185.43M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$166.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$144.22M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$139.16M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$92.36M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$31.17M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$16.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$29.35M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$13.22M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$14.61M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$14.29M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.90M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.31M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$24.55M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$45.78M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$43.64M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$20.12M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-45.78M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-43.64M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-20.12M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-24.55M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$1.64M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-190.00K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-61.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$761.00K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-190.00K	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.64M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$761.00K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-61.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-42.00M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-19.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-45.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.61M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-42.00M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.36M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-45.97M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-24.61M	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.53	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.68	USD	2 Qtrs
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.70	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.90	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.90	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.70	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.68	USD	2 Qtrs
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.53	USD	2 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.38M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.45M	shares	2 Qtrs
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.47M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.38M	shares	2 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.45M	shares	2 Qtrs
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.38M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.47M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.38M	shares	2 Qtrs

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-42.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-45.97M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$991.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$885.00K	USD	2 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$118.00K	USD	2 Qtrs
Non-cash interest expense	`NoncashInterestExpense`	$106.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$4.74M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$3.59M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-2.00K	USD	2 Qtrs
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.07M	USD	2 Qtrs
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-857.00K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-221.00K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-188.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.22M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.17M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.20M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.20M	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-444.00K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-386.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.82M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-37.59M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$486.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.02M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-486.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.02M	USD	2 Qtrs
Repayments of debt principal	`RepaymentsOfDebt`	$2.78M	USD	2 Qtrs
Payments of finance lease	`FinanceLeasePrincipalPayments`	$42.00K	USD	2 Qtrs
Payments of finance lease	`FinanceLeasePrincipalPayments`	$42.00K	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$140.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$16.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-26.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.68M	USD	2 Qtrs
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-44.99M	USD	2 Qtrs
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-38.64M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$160.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$160.96M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$240.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$332.00K	USD	2 Qtrs
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$154.00K	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.39M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$159.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$75.38M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.55M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.57M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$76.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$160.96M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$67.38M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$144.22M	USD	Point-in-time
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$140.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	324.00	shares	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.71M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.03M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.79M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.80M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-45.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-19.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-42.00M	USD	2 Qtrs
Ending balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$67.38M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$144.22M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.